Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 169 Cancer Biology PhD Projects, Programmes & Scholarships for Non-European Students

Discipline

Discipline

Biological Sciences

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

I am a non-European student


Cancer Biology PhD Projects, Programmes & Scholarships for Non-European Students

We have 169 Cancer Biology PhD Projects, Programmes & Scholarships for Non-European Students

A PhD in Cancer Biology would provide you with the opportunity to research a specific cancer in great detail. Whether you’re developing a new treatment, understanding the factors that allow a tumour to arise or innovating better diagnostic tests, you’ll be improving our understanding of cancer and saving lives.

What’s it like to do a PhD in Cancer Biology?

Doing a PhD in Cancer Biology, you’ll develop excellent laboratory skills, particularly in cell culture, working with RNA and studying the proteome. Most Cancer Biology projects link to other subjects and as such, you’ll have experience working with techniques from Cell Biology, Immunology and Genetics.

Some typical research topics in Cancer Biology include:

  • Developing novel diagnostic tests
  • Understanding a potential trigger of metastasis
  • Developing novel therapeutics to treat a specific cancer
  • The immune system and cancer interactions
  • Characterising the role of a specific tumour suppressor or oncogene in a certain cancer

Generally, Cancer Biology programmes are advertised on the university website with the research proposal, including the scope and primary aim of the research pre-determined by the supervisor. These projects are usually fully-funded.

It’s uncommon to propose your own research in Cancer Biology since the additional bench fees make self-funding difficult. It can also be tricky to find a supervisor with the interests that line up well with your suggested project that also have the equipment and expertise to supervise you through your PhD.

In your daily life you’ll be in the laboratory conducting experiments, reading the literature for new methods you could try, analysing old data, and talking to colleagues and your supervisor about your work. In the final year of your PhD you’ll submit a thesis of around 60,000 words that will contribute to the knowledge of your field and you’ll defend your work during your viva exam.

Entry requirements

The entry requirements for most Cancer Biology PhD programmes involve a Masters in a subject directly related to Biology, with at least a Merit or Distinction. If English isn’t your first language, you’ll also need to show that you have the right level of language proficiency.

PhD in Cancer Biology funding options

The Research Council responsible for funding Cancer Biology PhDs in the UK is the Biotechnology and Biological Sciences Research Council (BBSRC). They provide fully-funded studentships including a stipend for living costs, a consumables budget for bench fees and a tuition fee waiver. Students don’t apply directly to the BBSRC, you apply for advertised projects with this funding attached.

It’s uncommon for Cancer Biology PhD students to be ‘self-funded’ due to the additional bench fees. However, if you were planning to fund yourself it might be achievable (depending on your project) through the UK government’s PhD loan and part-time work.

read more

Is metabolic reprogramming the key to treatment failure in aggressive brain tumours? A multi-nuclear in vivo ultrahigh-field MRI approach.

Glioblastoma is the deadliest brain cancer with poor survival rates despite improved understanding of its genetic causes; novel treatments in lymphomas offer survival benefits for some people with lymphomas, but when treatments fail, the median survival time is ~5 months. Read more

Generative AI and Active Learning for Foundation Models Applied to Automated Segmentation of Multi-modal Images

This proposal focuses on automatically segmenting diverse medical imaging modalities such as MRI, CT, and pathology through the combined use of Foundation models, Active Learning and Generative AI (Artificial Intelligence). Read more

Exploring cancer transcriptomes with Nanopore long-read sequencing

Are you interested in cancer gene expression, immunology, and cutting-edge genomics/transcriptomics? Do you want to pursue a PhD in an environment supported by a supervisory team including immunologists and RNA biologists (Lagos, Kourtzelis), clinical oncologists (Vasudev), and leading industry experts (Oxford Nanopore Technologies)? If yes, this is the perfect opportunity for you. Read more

Obtaining insights into how a signalling hub protein Ras activates multiple effectors

The RAS family of small GTPases act as signalling hubs regulating cell proliferation and differentiation. They are highly conserved from yeast to humans, highlighting their fundamental biological roles. Read more

Revealing Reactivity in Cancer-Associated Heme Proteins: Novel Time-Resolved Structural Approaches

Indoleamine 2,3-dioxygenase 1 (IDO1) is a heme-containing enzyme involved in the degradation of tryptophan to kynurenine. Cancer cells upregulate IDO1 to escape normal immune responses and, in many cases, a high expression of IDO1 is connected to poor prognosis. Read more

Structural-guided PROTAC targeting of BMX to modulate apoptotic sensitivity in disease

What determines at the molecular level whether a cell lives or dies? Regulation of the cellular life–death switch is essential in healthy cells for normal foetal development and for the clearance of damaged cells. Read more

Filtering Results